Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$49.00
Provider: Wright Reports
$169.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Takeda Pharmaceutical issues consolidated full-year outlook for FY 2015 below I/B/E/S estimates


Thursday, 8 May 2014 02:00am EDT 

Takeda Pharmaceutical Co Ltd:Expects revenue to be 1,725 bln yen for FY ending March 2015.Sees operating profit at 150 bln yen.Sees net profit at 85 bln yen.Sees earnings per share at 107.67 yen.FY 2015 revenues of 1,730.66 billion yen, reported net profit of 103.52 billion yen – Thomson Reuters I/B/E/S. 

Company Quote

6046.0
93.0 +1.56%
1:50am EDT